The world is hungry for mRNA COVID vaccines like Pfizer’s, but short of vital components

Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap. Pfizer’s mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before year’s end. But Australia isn’t the only country eager to get its hand on […]
Continue reading »